Tag: Europe
-
Financial Asset Managers Supporting Net Zero Emissions
Thirty asset managers, directing investments worth some $9 trillion, agreed to encourage their clients to achieve global net zero greenhouse gas emission goals.
-
Bayer Gains Lung Cancer Therapy in $670M Deal
Global drug maker Bayer AG is licensing an engineered T-cell therapy to treat mesothelioma and other solid tumor cancers from biotech Atara Biotherapeutics.
-
Biotech Creating More Efficient Crispr Therapies
A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins.
-
Stem Cell Respiratory Therapy Licensed in $1.4B Deal
Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections.
-
Tech, Genomics Companies Form DNA Storage Alliance
Four companies from the computer technology and genomics industries are starting a coalition to advance DNA as a data storage medium.
-
Gene-Editing Enzyme Start-Up Gains $65M
A new company creating engineered enzymes for genome editing therapeutics is raising $65 million in its first venture funding round.
-
Oral Drug Delivery Company Acquired in $1.8B Deal
Emisphere Technologies, developers of a process that makes biologic drugs available as oral medicines is being acquired by drug maker Novo Nordisk.
-
Crispr Therapy Shown to Help Blood Disorder Patients
Interim clinical trial results show an experimental treatment derived from gene-edited stem cells relieves symptoms in patients with severe inherited blood diseases.
-
Trial Shows Covid-19 Vaccine Safety, Immune Response
First results from an early-stage clinical trial show an RNA-based vaccine to prevent Covid-19 infections is safe and produces a complex immune response.
-
200M Covid-19 Vaccine Doses Donated to Int’l Effort
Sanofi and GlaxoSmithKline are offering 200 million doses of their Covid-19 vaccine for a project devoted to making vaccines equitably available worldwide.